Axogen (AXGN) Operating Expenses (2010 - 2026)

Axogen's Operating Expenses history runs 17 years deep, the most recent figure standing at $49.0 million for Q1 2026.

• On a quarterly basis, Operating Expenses rose 33.96% year-over-year to $49.0 million in Q1 2026; TTM through Mar 2026 was $187.6 million, a 29.69% increase from a year earlier, with the FY2025 full-year figure at $175.2 million, up 20.61% from the prior year.
• Operating Expenses eased to $49.0 million in Q1 2026 per AXGN's latest filing, from $54.2 million in the prior quarter.
• Across five years, Operating Expenses topped out at $54.2 million in Q4 2025 and bottomed at $30.0 million in Q4 2022.
• The 5-year median for Operating Expenses is $36.6 million (2023), against an average of $38.3 million.
• Across the five-year window, Operating Expenses dropped 4.64% in 2022 and jumped 52.37% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $30.0 million in 2022, then rose by 17.37% to $35.2 million in 2023, then gained by 0.97% to $35.6 million in 2024, then soared by 52.37% to $54.2 million in 2025, then dropped by 9.52% to $49.0 million in 2026.
• Per Business Quant, the three latest AXGN Operating Expenses figures stand at $49.0 million (Q1 2026), $54.2 million (Q4 2025), and $44.1 million (Q3 2025).